Aerin Medical Inc. v. Neurent Medical Ltd. et al.

IPR2025-01125

Aerin Medical seeks IPR cancellation of Neurent's U.S. Patent 12,089,889 covering a nasal neuromodulation device, asserting obviousness over four prior‑art references and lack of written description.

Jurisdiction
US PTAB
Case Number
IPR2025-01125
Filing Date
24 June 2025
Status
ok

Related Cases

patentPGR2026-00008

Kia America, Inc. et al.vsEmerging Automotive LLC

Kia and Toyota have filed a PTAB post‑grant review petition challenging Emerging Automotive’s vehicle‑key sharing patent (US 12,337,715). Petitioners allege obviousness over four prior‑art references and assert lack of written description for key claim limitations. They seek institution and cancellation of claims 1‑24.

patentIPR2025-00694

DataDome S.A. et al.vsArkose Labs Holdings, Inc.

DataDome has filed a petition to review Arkose Labs’ ‘robot proof website’ patent (U.S. 9,148,427), seeking to invalidate the claims through inter partes review.

patentIPR2025-01164

Samsung Electronics Co., Ltd. et al.vsWilus Institute of Standards and Technology Inc.

Samsung Electronics has filed a petition for inter partes review of U.S. Patent 12,004,262, asserting that its four claims are obvious over several IEEE 802.11 draft and standard documents, as well as the Yang publication. The petition seeks institution of the IPR and cancellation of all claims.

patentIPR2025-00536

Samsung Electronics Co. Ltd. et al.vsMobile Data Technologies LLC

Samsung has filed an IPR petition challenging Mobile Data Technologies’ 9,032,039 patent covering mobile content sharing. The petition argues the claims are obvious over two prior‑art combinations and urges the Board to institute the review.

patentIPR2025-01420

Terumo BCT, Inc.vsHaemonetics Corporation

Terumo BCT has filed an IPR petition seeking cancellation of all 30 claims of Haemonetics’ plasma‑collection patent, arguing they are obvious over a suite of older apheresis technologies. The petition lists nine statutory grounds under 35 U.S.C. §103, each tied to specific prior‑art references.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call